Lead Scientist - Cancer Vaccines & Immunogenomics
Moderna Inc. · Cambridge, MA
FULL-TIME
Posted Nov 19, 2026
159K–286K a year
Job Description
Moderna is seeking a Principal Scientist to join the Cancer Vaccine and Bioinformatics Research (CV ) team in Cambridge, MA. This hands-on leadership role focuses on cancer genomics, immunogenomics, and multi-omics analysis to advance cancer-vaccine discovery and clinical development.
You will mentor scientists, design scalable computational workflows in Python/R, and collaborate across translational, clinical, and machine-learning teams to generate high-quality datasets and actionable insights.
We are seeking a motivated Lead Scientist
- Cancer Vaccines & Immunogenomics to join Moderna Inc. in Cambridge, MA, United States.
The Lead Scientist
- Cancer Vaccines & Immunogenomics role at Moderna Inc. is now open for applications in Cambridge, MA, United States.
Join us at Moderna Inc. as our next Lead Scientist
- Cancer Vaccines & Immunogenomics in Cambridge, MA, United States.
We are currently recruiting a Lead Scientist
- Cancer Vaccines & Immunogenomics for our team in Cambridge, MA, United States.
You will mentor scientists, design scalable computational workflows in Python/R, and collaborate across translational, clinical, and machine-learning teams to generate high-quality datasets and actionable insights.
We are seeking a motivated Lead Scientist
- Cancer Vaccines & Immunogenomics to join Moderna Inc. in Cambridge, MA, United States.
The Lead Scientist
- Cancer Vaccines & Immunogenomics role at Moderna Inc. is now open for applications in Cambridge, MA, United States.
Join us at Moderna Inc. as our next Lead Scientist
- Cancer Vaccines & Immunogenomics in Cambridge, MA, United States.
We are currently recruiting a Lead Scientist
- Cancer Vaccines & Immunogenomics for our team in Cambridge, MA, United States.
Additional Details
- City
- Cambridge
- State
- Massachusetts
- Country
- US
Apply and matching require a free OVN account. Browse listings anytime without signing in.